Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional) | RFA MH 21 120

Opportunity Information: Apply for RFA MH 21 120

The Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional) is an NIH grant opportunity (Funding Opportunity Number RFA-MH-21-120; CFDA 93.242) designed to strengthen the pipeline of mental health researchers working in low- and middle-income countries (LMICs) and other low-resource international settings. The core idea behind the program is that mental illnesses are a worldwide public health challenge, and that meaningful scientific progress can be accelerated when research questions, methods, and discoveries move across national and regional boundaries. By focusing on early-career investigators, the program aims to help talented scientists transition from the formative stages of their careers into independent research leaders with sustained, long-term commitments to mental health research.

This funding supports the launch of an innovative research program rather than a one-off project. Applicants are expected to propose work that can meaningfully advance understanding of mental illnesses and, importantly, do so in ways that fit the realities of lower-resource settings. The opportunity is broad in the kinds of science it will fund: basic research (for example, foundational studies that clarify mechanisms or risk pathways), translational research (work that connects basic findings to practical applications), clinical research (including studies involving patients, interventions, and outcomes), and services research (such as studies on how care is delivered, accessed, financed, or improved in real-world systems). The emphasis is on research with the potential to transform how mental illnesses are understood, prevented, diagnosed, or treated in settings where resources, infrastructure, and specialist capacity may be limited.

The mechanism is an R01 research project grant, and clinical trials are allowed but not required, as reflected by the “Clinical Trial Optional” designation. In practical terms, that means an applicant can propose either a clinical trial (if the aims and design justify it) or a non-trial research approach, and both can be responsive to the announcement as long as the work aligns with the program’s mental health mission and focus on LMIC or similarly resource-constrained contexts. The sponsor agency is the National Institutes of Health, and the opportunity falls under the NIH mental health portfolio (as indicated by the “MH” identifier in the funding announcement).

Eligibility includes a range of applicant organizations beyond typical U.S.-based institutions. The announcement lists non-domestic (non-U.S.) entities, meaning foreign organizations are explicitly eligible to apply. It also includes eligible U.S. federal government agencies and U.S. territories or possessions. This structure reinforces the cross-border intent of the program and signals that NIH is open to supporting strong research environments and leadership located outside the United States, particularly when the proposed work directly addresses mental health needs and scientific questions relevant to LMIC settings.

Key administrative details in the source data include an award ceiling listed as 500,000 (as provided in the record), an original closing date of 2021-12-09, and a creation date of 2021-02-23. The funding instrument is a discretionary grant. While the record shows “ExpectedAwards:” without a number, the overall framing indicates a competitive award intended for a select group of promising early-career investigators.

Overall, this opportunity is best understood as a career-launching research grant for early-stage scientists who want to build an independent mental health research program rooted in the challenges and constraints of low-resource international settings. It prioritizes innovation, the potential for high impact on mental health outcomes, and the development of researchers who will remain committed to mental health science over the long term.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
• This funding opportunity was created on 2021-02-23.
• Applicants must submit their applications by 2021-12-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $500,000.00 in funding.
• Eligible applicants include: Others.

Apply for RFA MH 21 120

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: